Orgalutran®

DRUG2 trials

Sponsors

Organon and Co, University Hospital, Ghent

Conditions

Fertility PreservationIn Vitro FertilizationInfertilityOvarian StimulationPreimplantation Genetic TestingQuality of Life

Phase 2

Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)

CompletedNCT00702806

Organon and CoInfertility, In Vitro Fertilization

Start: 2001-07-01End: 2002-10-15Updated: 2024-08-15

Phase 4

PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study

RecruitingNCT06175832

University Hospital, GhentFertility Preservation, Ovarian Stimulation, Preimplantation Genetic Testing +1

Start: 2025-01-27End: 2027-12-31Target: 60Updated: 2025-12-26